Applied Therapeutics

Yahoo Finance • 2 days ago

Applied Therapeutics promotes two executives to leadership roles

NEW YORK - Applied Therapeutics, Inc. (NASDAQ:APLT), a biopharmaceutical company with a market capitalization of approximately $50 million, announced on Tuesday the promotion of Evan Bailey, MD, to Chief Medical Officer and Dottie Caplan t... Full story

Yahoo Finance • 2 days ago

Applied Therapeutics Announces Key Leadership Appointments

Evan Bailey, MD, promoted to Chief Medical Officer, succeeding Riccardo Perfetti, MD, PhDDottie Caplan promoted to Executive Vice President, Patient Advocacy and Government Affairs NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Applied The... Full story

Yahoo Finance • last month

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Slowing of progression of disease observed via MRI at 24 months Improvements in outcomes and reduction in sorbitol maintained through 24 months Statistically significant correlation between absolute reduction in sorbitol and change in 10... Full story

Yahoo Finance • last month

Applied Therapeutics Reports First Quarter 2025 Financial Results

- Company to present full 12-month clinical data and new topline 18-month and 24-month data from INSPIRE registrational Phase 3 trial of govorestat in CMT-SORD Deficiency at the Peripheral Nerve Society 2025 Annual Meeting - Review of gov... Full story

Yahoo Finance • 2 months ago

NET Power Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. June 17, 2025 Deadline to file Lead Plaintiff Motion

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 22, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises NET Power Inc. ("NET Power " or the "Company") (NASDAQ: APLT) investo... Full story

Yahoo Finance • 2 months ago

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results

-  Appointed John H. Johnson as Executive Chairman; Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer; and Reena Thomas Colacot as Vice President and Head of Quality NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Applied Therapeuti... Full story

Yahoo Finance • 3 months ago

Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission

NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indi... Full story

Yahoo Finance • 4 months ago

Applied Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The laws... Full story

Yahoo Finance • 4 months ago

DEADLINE ALERT for APLT and KSPI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the d... Full story

Yahoo Finance • 4 months ago

APLT FRAUD ALERT: A Class Action has been Filed against Applied Therapeutics for Securities Fraud – Contact BFA Law by Today’s Deadline (NASDAQ:APLT)

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company’s senior executives f... Full story

Yahoo Finance • 4 months ago

APLT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT

NEW YORK, Feb. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates i... Full story

Yahoo Finance • 4 months ago

APLT COURT NEWS: Applied Therapeutics has been Sued for Securities Fraud; Contact BFA Law by February 18 if You Lost Money (NASDAQ:APLT)

NEW YORK, Feb. 16, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company’s senior executives f... Full story

Yahoo Finance • 4 months ago

APLT 截止日期通知：享譽全球的律師事務所 ROSEN 鼓勵 Applied Therapeutics, Inc. 投資者在對 APLT 提出證券集體訴訟的重要截止日期 2 月 18 日前聘請律師

紐約, Feb. 15, 2025 (GLOBE NEWSWIRE) -- 事因：全球投資者權益律師事務所 Rosen Law Firm 提醒在 2024 年 1 月 3 日至 2024 年 12 月 2 日（包括首尾兩日，簡稱「集體訴訟期」）期間購買了 Applied Therapeutics, Inc. (NASDAQ: APLT) 證券之人士注意，重要的首席原告截止日期為 2025 年 2 月 18 日。 影響：如果您在集體訴訟期內購買了 Applied Th... Full story

Yahoo Finance • 4 months ago

APLT DEADLINE NOTICE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT

NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates i... Full story

Yahoo Finance • 4 months ago

APLT Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit

RADNOR, Pa., Feb. 14, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern... Full story

Yahoo Finance • 4 months ago

APLT SHAREHOLDER ACTION: Applied Therapeutics 80% Stock Drop Prompts Class Action; Contact BFA Law by February 18 if You Suffered Losses (NASDAQ:APLT)

NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: APLT) and certain of the Company’s senior executives f... Full story

Yahoo Finance • 4 months ago

Applied Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. February 18, 2025 Deadline to file Lead Plaintiff Motion.

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Feb. 13, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (... Full story

Yahoo Finance • 4 months ago

APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The laws... Full story

Yahoo Finance • 4 months ago

INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - APLT

SAN DIEGO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, in... Full story

Yahoo Finance • 4 months ago

APLT LAWSUIT ALERT: The Gross Law Firm Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during the class period listed are encour... Full story